395 related articles for article (PubMed ID: 10563675)
1. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
[TBL] [Abstract][Full Text] [Related]
2. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
3. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
[TBL] [Abstract][Full Text] [Related]
4. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
5. Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo.
Kuriyama S; Kikukawa M; Masui K; Okuda H; Nakatani T; Akahane T; Mitoro A; Tominaga K; Tsujinoue H; Yoshiji H; Okamoto S; Fukui H; Ikenaka K
Int J Cancer; 1999 Oct; 83(3):374-80. PubMed ID: 10495430
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
[TBL] [Abstract][Full Text] [Related]
7. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity.
Rogulski KR; Kim JH; Kim SH; Freytag SO
Hum Gene Ther; 1997 Jan; 8(1):73-85. PubMed ID: 8989997
[TBL] [Abstract][Full Text] [Related]
8. [The killing effects of two prodrug sensitivity genes on human pancreatic carcinoma cells PC-2].
Zhang L; Liu T; Cui Q
Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):412-5. PubMed ID: 11244949
[TBL] [Abstract][Full Text] [Related]
9. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
Xie Y; Gilbert JD; Kim JH; Freytag SO
Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
[TBL] [Abstract][Full Text] [Related]
11. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor effects of cytosine deaminase and HSV-tk double suicide gene with adenovirus mediation on rectal cancer cells].
Li S; Yu B; An P
Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):577-9. PubMed ID: 11758189
[TBL] [Abstract][Full Text] [Related]
13. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
Zhao Y; Zhang X; Hui H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
[TBL] [Abstract][Full Text] [Related]
14. Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo.
Uckert W; Kammertöns T; Haack K; Qin Z; Gebert J; Schendel DJ; Blankenstein T
Hum Gene Ther; 1998 Apr; 9(6):855-65. PubMed ID: 9581908
[TBL] [Abstract][Full Text] [Related]
15. Suicide gene therapy on LNCaP human prostate cancer cells.
Yoshimura I; Suzuki S; Tadakuma T; Hayakawa M
Int J Urol; 2001 Jul; 8(7):S5-8. PubMed ID: 11442669
[TBL] [Abstract][Full Text] [Related]
16. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy.
Boucher PD; Im MM; Freytag SO; Shewach DS
Cancer Res; 2006 Mar; 66(6):3230-7. PubMed ID: 16540675
[TBL] [Abstract][Full Text] [Related]
18. Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model.
Moriuchi S; Wolfe D; Tamura M; Yoshimine T; Miura F; Cohen JB; Glorioso JC
Gene Ther; 2002 May; 9(9):584-91. PubMed ID: 11973634
[TBL] [Abstract][Full Text] [Related]
19. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
Wildner O; Blaese RM; Morris JC
Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
[TBL] [Abstract][Full Text] [Related]
20. Treatment of thyroid carcinoma cells with four different suicide gene/prodrug combinations in vitro.
Nishihara E; Nagayama Y; Narimatsu M; Namba H; Watanabe M; Niwa M; Yamashita S
Anticancer Res; 1998; 18(3A):1521-5. PubMed ID: 9673364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
